Philips continues collaborations to improve radiation oncology
Royal Philips Electronics and RaySearch Laboratories AB, Stockholm, Sweden, have recently announced plans to expand their strategic relationship to develop advanced image guided and adaptive radiation therapy solutions. Philips' recent partnerships, plus the company's full oncology platform are being showcased at the American Association of Physicists in Medicine (AAPM) annual meeting in Seattle, July 24-28.
Philips and RaySearch have been collaborating since 2000 and now plan to launch a joint development agreement for an expanded relationship in image guided and adaptive radiation therapy. The companies already have a long-standing research collaboration in the field and are forming the multi-center Image Guided Adaptive Radiotherapy (IGART) Consortium, to be led by Dr. David Jaffray of Princess Margaret Hospital, Toronto. The new joint development agreement will mark the beginning of a product phase of the alliance, and at the same time the joint research will continue under the direction of the IGART Consortium, Philips said.
"Adaptive radiation therapy will be the major development area in the future of radiation oncology," said Johan Löf, president and CEO of RaySearch Laboratories in a release. "This new technology plans to increase the geometrical precision by taking into account changes in the patient's anatomy during the actual treatment," added Löf.
Philips is also reinforcing its leadership role in radiation oncology with its continued collaboration with Calypso Medical Technologies Inc., a new company with novel non-ionizing tumor localization technology.
Also at AAPM, Philips is highlighting its global commercial shipment of the Brilliance CT Big Bore Oncology system, which is designed for radiation treatment planning and developed in collaboration with luminary hospital sites around the world to establish clinical capabilities.
Philips and RaySearch have been collaborating since 2000 and now plan to launch a joint development agreement for an expanded relationship in image guided and adaptive radiation therapy. The companies already have a long-standing research collaboration in the field and are forming the multi-center Image Guided Adaptive Radiotherapy (IGART) Consortium, to be led by Dr. David Jaffray of Princess Margaret Hospital, Toronto. The new joint development agreement will mark the beginning of a product phase of the alliance, and at the same time the joint research will continue under the direction of the IGART Consortium, Philips said.
"Adaptive radiation therapy will be the major development area in the future of radiation oncology," said Johan Löf, president and CEO of RaySearch Laboratories in a release. "This new technology plans to increase the geometrical precision by taking into account changes in the patient's anatomy during the actual treatment," added Löf.
Philips is also reinforcing its leadership role in radiation oncology with its continued collaboration with Calypso Medical Technologies Inc., a new company with novel non-ionizing tumor localization technology.
Also at AAPM, Philips is highlighting its global commercial shipment of the Brilliance CT Big Bore Oncology system, which is designed for radiation treatment planning and developed in collaboration with luminary hospital sites around the world to establish clinical capabilities.